Keyword: Forest Laboratories

Rebel investors earlier this month called for changes at Allergan, and now the company has appointed a new director.

Allergan CEO Brent Saunders has said it before, and he’ll say it again: He’s not interested in buying Valeant.

Allergan Executive Chairman Paul Bisaro is stepping aside for rising star Brent Saunders--again.

@FiercePharma: Roche unveils more plans for plant expansions in Switzerland. Story | Follow @FiercePharma @TracyStaton: If AstraZeneca were Harry Potter, would that make Pfizer Voldemort? More |...

@FiercePharma: Chinese police pick up AstraZeneca sales rep for questioning. AZN says no reason to think it's part of bribery probe. Report | Follow @FiercePharma @CarlyHFierce: Reuters says...